It has thus been suggested that molecular diagnosis of FSHD can be based on genetic (presence or absence of DRA) and epigenetic (D4Z4 hypomethylation and/or SMCHD1 variant) characteristics. This evidence concerns the gene SMCHD1 and facioscapulohumeral muscular dystrophy.